ZA200408071B - Combination therapy for the treatment of cancer. - Google Patents

Combination therapy for the treatment of cancer.

Info

Publication number
ZA200408071B
ZA200408071B ZA200408071A ZA200408071A ZA200408071B ZA 200408071 B ZA200408071 B ZA 200408071B ZA 200408071 A ZA200408071 A ZA 200408071A ZA 200408071 A ZA200408071 A ZA 200408071A ZA 200408071 B ZA200408071 B ZA 200408071B
Authority
ZA
South Africa
Prior art keywords
cancer
treatment
combination therapy
therapy
combination
Prior art date
Application number
ZA200408071A
Inventor
Anderson Joseph Ryan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200408071B publication Critical patent/ZA200408071B/en

Links

ZA200408071A 2002-04-16 2004-10-06 Combination therapy for the treatment of cancer. ZA200408071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0208680A GB0208680D0 (en) 2002-04-16 2002-04-16 Combination therapy

Publications (1)

Publication Number Publication Date
ZA200408071B true ZA200408071B (en) 2005-10-18

Family

ID=9934913

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200408071A ZA200408071B (en) 2002-04-16 2004-10-06 Combination therapy for the treatment of cancer.

Country Status (2)

Country Link
GB (1) GB0208680D0 (en)
ZA (1) ZA200408071B (en)

Also Published As

Publication number Publication date
GB0208680D0 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
IL164599A0 (en) Combination therapy for the treatment of cancer
IL251270A0 (en) Cancer treatment
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
EP1599196A4 (en) Combination therapies for the treatment of cancer
EP1635813A4 (en) Combination therapy for the treatment of dyslipidemia
EP1311262A4 (en) Cancer treatment by combination therapy
EP1482970A4 (en) Cancer therapy
EP1534074A4 (en) Combination therapy for the treatment of obesity
EP1613308A4 (en) Novel methods for the treatment of cancer
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
HUP0500424A3 (en) Combination therapy for the treatment of cancer
AU2003300791A1 (en) Combination therapy for the treatment of pain
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
MXPA03007036A (en) Method of cancer therapy.
AU2003223538A1 (en) Methods for the treatment of cancer
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
LT1496918T (en) Use of sodium meta-arsenite for the treatment of tumours
MXPA03006412A (en) Methods of administering epothilone analogs for the treatment of cancer.
GB0226595D0 (en) Cancer therapy determination
AU2003231803A8 (en) Treatment of cancer with mefloquire
ZA200408071B (en) Combination therapy for the treatment of cancer.
EP1463511A4 (en) Combination cancer therapy